Cervical cancer systemic inflammation score: a novel predictor of prognosis

Ru-ru Zheng; Min Huang; Chu Jin; Han-chu Wang; Jiang-tao Yu; Lin-chai Zeng; Fei-yun Zheng; Feng Lin

doi:10.18632/oncotarget.7378

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Cervical cancer systemic inflammation score: a novel predictor of prognosis

Ru-ru Zheng, Min Huang, Chu Jin, Han-chu Wang, Jiang-tao Yu, Lin-chai Zeng, Fei-yun Zheng and Feng Lin _

PDF | HTML | How to cite

Oncotarget. 2016; 7:15230-15242. https://doi.org/10.18632/oncotarget.7378

Metrics: PDF 2392 views | HTML 2570 views | ?

Abstract

Ru-ru Zheng1*, Min Huang1*, Chu Jin2*, Han-chu Wang1, Jiang-tao Yu1, Lin-chai Zeng1, Fei-yun Zheng1 and Feng Lin1

1 The Department of Gynecology, First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, PR China

2 The Department of Information and Engineering, Wenzhou Medical University, Zhejiang, Wenzhou, PR China

* These authors have contributed equally to this work

Correspondence to:

Fei-yun Zheng, email:

Feng Lin, email:

Keywords: cervical cancer, platelet to lymphocyte ratio, albumin, overall survival, disease free survival

Received: November 24, 2015 Accepted: February 01, 2016 Published: February 14, 2016

Abstract

Inflammation contributes to development and progression in a variety of cancers, including cervical cancer. We developed a novel cervical cancer systemic inflammation score (CCSIS) based on the preoperative platelet-to-lymphocyte ratio (PLR) and serum albumin levels. A retrospective analysis of clinical data from 795 patients with operable cervical cancer was then conducted to investigate the prognostic value of CCSIS and its association with the patients’ clinicopathological features, overall survival (OS), and disease-free survival (DFS). CCSIS was predictive of OS and DFS. High CCSIS was correlated with more advanced FIGO stages, poor tumor differentiation, and the presence of PLN and LVSI. Both albumin levels and the PLR were independent prognostic indicators for operable cervical cancer. The use of the CCSIS could improve risk stratification and traditional clinicopathological analysis in cervical cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7378

Publication Alerts

Clinical Research Papers:

Cervical cancer systemic inflammation score: a novel predictor of prognosis

Abstract